Sintetinės biologijos organizacija - financials and debts
Company age: 10 y. 5 mo.
Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | - | 0 | 19,417 | 500 | 35,489 | 38,485 | 36,143 | 37,864 |
| Profit before tax | - | - | - | - | 0 | 0 | 0 | 0 |
| Net profit | - | - | - | - | 0 | 0 | 0 | 0 |
| Equity | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Liabilities | 8,077 | 7,521 | 1,855 | 3,657 | 691 | 1,377 | 4,301 | 809 |
| Non-current assets | 0 | 0 | 0 | 0 | 6,615 | 4,811 | 3,007 | 1,203 |
| Current assets | 30,758 | 29,082 | 24,249 | 32,645 | 20,735 | 25,062 | 26,354 | 10,113 |
| Total assets | 30,758 | 29,082 | 24,249 | 32,645 | 27,350 | 29,873 | 29,361 | 11,316 |
|
Financial indicators
|
||||||||
| Revenue change y/y | - | - | - | -97.4% | +6997.8% | +8.4% | -6.1% | +4.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | - | - | - | - | 0.0% | 0.0% | 0.0% | 0.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | - | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | - | - | - | 0.0% | 0.0% | 0.0% | 0.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | 0.0% | 0.0% | 0.0% | 0.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Social security debts
The company had no debts to Sodra
VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Sintetines biologijos organizacija (code 304224244) is an Association engaged in research and development in natural sciences. In 2025, it generated revenue of €37.9K, up 4.8% year on year from €36.1K in 2024, and slightly below €38.5K in 2023, which points to a broadly stable revenue profile over the last three years. The 2025 balance sheet shows a much smaller asset base than in prior years: total assets declined to €11.3K from €29.4K in 2024 and €29.9K in 2023. Liabilities also decreased to €809 in 2025 after €4.3K in 2024 and €1.4K in 2023. Short-term assets accounted for most of the 2025 assets at €10.1K, while long-term assets were €1.2K. The reported asset turnover of 3.35x for 2025 indicates that revenue was generated efficiently relative to the asset base. Profit figures are not provided, so profitability and return metrics cannot be assessed from the available information.